ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 19 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,730,241 | +6.1% | 46,411,000 | 0.0% | 0.13% | -17.4% |
| Q2 2023 | $23,308,486 | +24.3% | 46,411,000 | 0.0% | 0.16% | -11.0% |
| Q1 2023 | $18,751,436 | -25.9% | 46,411,000 | 0.0% | 0.18% | -59.2% |
| Q4 2022 | $25,320,496 | -3.1% | 46,411,000 | 0.0% | 0.44% | +52.1% |
| Q3 2022 | $26,134,000 | +3.5% | 46,411,000 | 0.0% | 0.29% | -1.7% |
| Q2 2022 | $25,262,000 | +4.3% | 46,411,000 | 0.0% | 0.30% | +2.4% |
| Q1 2022 | $24,217,000 | -2.2% | 46,411,000 | 0.0% | 0.29% | +7.8% |
| Q4 2021 | $24,770,000 | – | 46,411,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 29,679,000 | $23,720,000 | 7.42% |
| SILVERBACK ASSET MANAGEMENT LLC | 11,750,000 | $6,487,175 | 0.92% |
| DCF Advisers, LLC | 1,550,000 | $884,000 | 0.57% |
| Context Capital Management, LLC | 14,764 | $8,274,000 | 0.56% |
| AGF Investments LLC | 7,000,000 | $3,872,000 | 0.36% |
| WHITEBOX ADVISORS LLC | 19,600,000 | $10,682,000 | 0.30% |
| Pentwater Capital Management LP | 46,411,000 | $26,134,000 | 0.29% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $11,591,000 | 0.27% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 24,000,000 | $13,275,000 | 0.24% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 14,900,000 | $8,493,000 | 0.12% |